NCT06935409 2026-04-09Study of HS-20093 Versus Gemcitabine in Combination With Docetaxel in Treatment of Osteosarcoma After Previous Second-line Treatment FailureHansoh BioMedical R&D CompanyPhase 3 Active not recruiting117 enrolled